Smoking cessation guidelines for health professionals: An update

Thorax

Volumn 55, Issue 12, 2000, Pages 987-999

  West, R ^a   McNeill, A ^b   Raw, M ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Freelance Consultant   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bupropion; Guidelines; Nicotine replacement therapy; Smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE;

DRUG EFFICACY; HEALTH CARE PERSONNEL; HUMAN; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PURCHASING; REVIEW; SMOKING CESSATION;

BEHAVIOR THERAPY; BUPROPION; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; NATIONAL HEALTH PROGRAMS; NICOTINE; PATIENT EDUCATION; PREGNANCY; SMOKING CESSATION; STATE MEDICINE;

EID: 0033662997     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.12.987     Document Type: Review

References (70)

1. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system
2. Guidance for commissioners on the cost effectiveness of smoking cessation interventions
3. SRNT, treatment database treatobacco.net
4. Physician advice for smoking cessation
5. Effect of general practitioners' advice against smoking
6. How does physician advice influence patient behavior? Evidence for a priming effect
7. The emergency department as a potential site for smoking cessation intervention: A randomized, controlled trial
8. Predictors of smoking cessation following physicians' counseling
9. Smoking cessation and smoking patterns in the general population: A one-year follow-up
10. Smoking cessation activities by GPs and practice nurses
11. Factors influencing discussion of smoking between general practitioners and patients who smoke: A qualitative study
12. Factors associated with the provision of anti-smoking advice by general practitioners
13. Qualitative study of patients' perceptions of doctors' advice to quit smoking: Implications for opportunistic health promotion
14. Health promotion and the human response to loss: Clinical implications of a decade of primary health care research
15. Individual behavioural counselling for smoking cessation
16. 1. The Lung Health Study
17. Nursing interventios for smoking cessation
18. Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: Randomised trial
19. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: A randomised controlled trial in Scotland
20. A randomised controlled trial of a smoking cessation intervention based in community pharmacies
21. Group behaviour therapy programmes for smoking cessation
22. A review of tobacco smoking in adolescents: Treatment implications
23. Interventions for promoting smoking cessation during pregnancy
24. Recommended cessation counselling for pregnant women who smoke: A review of the evidence
25. A prospective intervention study of stopping smoking in pregnancy in a routine antenatal care setting
26. Randomised controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy
27. Do social support interventions ('buddy systems') aid smoking cessation? A review
28. Does exercise aid smoking cessation? A systematic review
29. Promoting smoking cessation in general practice
30. Nicotine replacement to aid smoking cessation
31. Nicotine replacement therapy for smoking cessation
32. Randomised comparative trial of nicotine polacrilex, a transdermal patch, nasal spray and an inhaler
33. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day
34. Over-the-counter nicotine patch therapy for smoking cessation: Results from randomized, double-blind, placebo-controlled, and open label trials
35. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation
36. Public health benefit of over-the-counter nicotine medications
37. Commentary: Progress on nicotine replacement therapy for
38. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: A placebo-controlled study
39. Transdermal nicotine replacement for hospitalized patients: A randomized clinical trial
40. Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Report by a Subcommittee of the Research Committee of the British Thoracic Society
41. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy
42. The maternal and fetal physiologic effects of nicotine
43. Effect of nicotine on human fetal blood flow
44. Gender differences and low birth weight with maternal smokeless tobacco use in pregnancy
45. Individual differences in preference for and responses to four nicotine replacement products
46. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993
47. Usage patterns of transdermal nicotine when purchased as a nonprescription medicine from pharmacies
48. A comparison of sustained-release bupropion and placebo for smoking cessation
49. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
50. Self-help interventions for smoking cessation
51. Telephone counseling for smoking cessation: Rationales and metaanalytic review of evidence
52. Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions
53. Impact of a telephone helpline for smokers who called during a mass media campaign
54. Enhancing the impact of groups: An evaluation of two group formats for smokers
55. Withdrawal-oriented therapy for smokers
56. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice
57. Prescription of transdermal nicotine patches for smoking cessation in general practice: Evaluation of cost-effectiveness